M., Nikooienejad A., Robins D
Weight loss drug lawsuits are being filed for patients who suffered serious side effects from prescription medications
In April 2026, Canada became the first G7 country to approve a generic version of semaglutide for adults with type 2 diabetes
Active Akt phosphorylates multiple targets including Bad (preventing it from inhibiting anti-apoptotic Bcl-2), MDM2 (stabilizing p53), FOXO transcription factors (preventing pro-apoptotic gene expression), mTOR (promoting protein synthesis)
Acute Renal Insufficiency Associated With Consumption of Hydrocodone- and Morphine-Adulterated Kratom (Mitragyna Speciosa)
So, none of these studies suggest a cause-and-effect relationship between semaglutide medications and hair loss